Trastuzumab Terminated Phase 1 / 2 Trials for ER-positive Breast Cancer / Her2-Positive Breast Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs